SPECIAL NOTICE
A -- REQUEST FOR SOLUTION SUMMARIES for ARPA-H ADAPT
- Notice Date
- 3/14/2024 3:07:41 PM
- Notice Type
- Special Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) Bethesda MD 208920004 USA
- ZIP Code
- 208920004
- Solicitation Number
- ARPA-H-SN-24-104
- Response Due
- 3/29/2024 7:00:00 AM
- Archive Date
- 04/13/2024
- Point of Contact
- SEE DESCRIPTION SECTION
- E-Mail Address
-
do_NOT_use_THIS_email_ADDRESS@arpa-h.gov
(do_NOT_use_THIS_email_ADDRESS@arpa-h.gov)
- Description
- The Advanced Research Projects Agency for Health (ARPA-H) is inviting all parties interested in the ARPA-H ADvanced Analysis for Precision cancer Therapy (ADAPT) program to submit a Solution Summary for review and feedback. The ARPA-H ADAPT Module Announcement, ARPA-H-MAI-24-01-03 is posted on SAM.gov and should be leveraged in the development of all Solution Summary submissions. � All questions technical or administrative shall be submitted to ARPA-H Ask-A-Question: �https://solutions.arpa-h.gov/Ask-A-Question/ All Solution Summary submissions shall be submitted to:�https://solutions.arpa-h.gov All parties interested in submitting a proposal to the ARPA-H ADAPT Module Announcement (ARPA-H-MAI-24-01-03) are strongly encouraged to submit a Solution Summary in accordance with this Special Notice (SN); however, submission of a Solution Summary is not required to submit a proposal to the ARPA-H ADAPT Module Announcement. No awards will be made, nor funding provided as a result of Solution Summary submissions.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/f0e9b3adcbc147708e152e0bf12fc998/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06996551-F 20240316/240314230047 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |